In 1869, a group of Massachusetts reformers persuaded the state to try a simple idea: counting. The Second Industrial Revolution was belching its way through New England, teaching mill and factory ...

Right now, many companies are worried about how to get more employees to use AI. After all, the promise of AI reducing the burden of some work—drafting routine documents, summarizing information, and ...

In the past week, automaker Stellantis and retailer Home Depot became the latest major companies to call employees back to the office five days a week. They join employers like Instagram, Paramount ...

Aggressive RCC has a greater effect on survival of patients younger than 35 years. Although renal cell carcinoma (RCC) is more commonly found in adults older than 60 years, recent data show a rising ...

Technological change has reshaped job markets for centuries. But the benefits have not always been widely shared. As AI and digital technologies transform today’s workplace even those at the forefront ...

Stage 4 RCC is metastatic, with common spread to lungs, bones, liver, brain, and adrenal glands. Understanding IMDC risk is crucial for treatment planning. Systemic therapies, including combination ...

To join the CNBC Technology Executive Council, go to cnbccouncils.com/tec A research team at Harvard studying workers at Procter & Gamble and Boston Consulting Group ...

Lin Lin, MD, highlights a phase 2 trial of neoadjuvant SAbR followed by surgery in patients with newly diagnosed renal cell carcinoma and caval tumor thrombus. Data presented at 2025 Society of ...

For the 13th year, employee survey firm Energage has partnered with the Union-Tribune to determine the best places to work in San Diego County. Energage administers an employee survey that covers 26 ...

Billionaire Elon Musk is signaling that artificial intelligence and robotics could eliminate the need to work in the next few decades. Musk attended the U.S.-Saudi Investment Forum and was asked on a ...

The last time I wrote about Allogene Therapeutics, Inc. (ALLO) it was in a Seeking Alpha article entitled "Allogene: Two End Of 2024 Data Readouts With Improved Allogeneic CAR-T Products." I noted the ...

Black patients exhibited higher prevalence of rare, aggressive non-clear cell RCC subtypes compared to non-Black patients. Black patients were diagnosed at younger ages with smaller tumors, resulting ...